Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)

被引：0
|
作者：
Piekarz, Richard [1 ]
Wright, John [2 ]
Frye, Robin [1 ]
Allen, Steven L. [3 ]
Craig, Michael [4 ]
Geskin, Larisa [5 ]
Hutchins, Laura [6 ]
Joske, David [7 ]
Kirschbaum, Mark [8 ]
Leonard, John P. [9 ]
Prince, Miles [10 ]
Reeder, Craig B. [11 ]
Jaffe, Elaine [1 ]
Bates, Susan [12 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] IDB CTEP NCI, Rockville, MD USA
[3] N Shore Univ, Hosp LIJ, Lake Success, NY USA
[4] Mary Babb Randolph Canc Ctr, Morgantown, WV USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[7] Sir Charles Gairdner Hosp, Haematol Care Ctr, Perth, WA, Australia
[8] City Hope Natl Med Ctr, Div Hematol, Duarte, CA 91010 USA
[9] Weill Cornell Med Coll, New York, NY USA
[10] Peter MacCallum Canc Inst, Melbourne, Australia
[11] Mayo Clin Arizona, Scottsdale, AZ USA
[12] NCI, Bethesda, MD 20892 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：555 / 556
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study
    Iyer, Swaminathan P.
    Huen, Auris
    Ai, Weiyun Z.
    Jagadeesh, Deepa
    Lechowicz, Mary J.
    Okada, Craig
    Feldman, Tatyana A.
    Ghione, Paola
    Alderuccio, Juan P.
    Champion, Rebecca
    Kim, Seo-Hyun
    Mohrbacher, Ann
    Routhu, Kasi, V
    Barde, Prajak
    Nair, Ajit M.
    Haverkos, Bradley M.
    HAEMATOLOGICA, 2024, 109 (01) : 209 - 219
  • [42] A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Bennani, N. Nora
    Pederson, Levi D.
    Atherton, Pamela
    Micallef, Ivana
    Colgan, Joseph P.
    Thanarajasingam, Gita
    Nowakowski, Grzegorz
    Witzig, Thomas E.
    Feldman, Andrew L.
    Ansell, Stephen M.
    BLOOD, 2019, 134
  • [43] A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Jin, Jie
    Cen, Hong
    Zhou, Keshu
    Xu, Xiaohong
    Li, Fei
    Yang, Haiyan
    Li, Zhiming
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    Shu, Yang
    Li, Fei
    Wang, Zhen
    BLOOD, 2021, 138
  • [44] A MULTICENTER PHASE II STUDY OF MOGAMULIZUMAB (KW-0761) IN PATIENTS WITH RELAPSED PERIPHERAL OR CUTANEOUS T-CELL LYMPHOMA
    Hatake, K.
    Ogura, M.
    Ishida, T.
    Taniwaki, M.
    Ando, K.
    Tobinai, K.
    Yamamoto, K.
    Tsukasaki, K.
    Tomonaga, M.
    Ueda, R.
    ANNALS OF ONCOLOGY, 2013, 24 : 55 - 55
  • [45] Lack of Response to Romidepsin in Children with Relapsed / Refractory Peripheral T -Cell Lymphoma (PTCL): A Single Centre Experience
    Tandon, S.
    Bartram, J.
    Punnett, A.
    Hitzler, J.
    Davidson, S.
    Villani, A.
    Shlien, A.
    Malkin, D.
    Abla, O.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S271 - S272
  • [46] A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)
    Chavez, Julio C.
    Foss, Francine M.
    William, Basem M.
    Brammer, Jonathan E.
    Smith, Sonali M.
    Prica, Anca
    Zain, Jasmine M.
    Tuscano, Joseph M.
    Glenn, Martha
    Mehta-Shah, Neha
    Wang, Ben X.
    Zantinge, Stephanie
    Wang, Lisa
    Zhang, Ling
    Boutrin, Anmarie
    Zhao, Weiguang
    Cheng, Lily
    Standifer, Nathan
    Carlesso, Gianluca
    Moscow, Jeffrey
    Siu, Lillian
    BLOOD, 2020, 136
  • [47] Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Casadei, Beatrice
    Chiappella, Annalisa
    Corradini, Paolo
    Derenzini, Enrico
    Dodero, Anna
    Farina, Lucia
    Gandolfi, Letizia
    Ladetto, Marco
    Monaco, Federico
    Orsucci, Lorella
    Quirini, Federica
    Salvi, Flavia
    Spina, Francesco
    Stefoni, Vittorio
    Tonialini, Lorenzo
    Vitolo, Umberto
    Argnani, Lisa
    Zinzani, Pier Luigi
    BLOOD, 2015, 126 (23)
  • [48] INTERIM RESULTS OF A PHASE II STUDY OF FONDAZIONE ITALIANA LINFOMI ON GEMCITABINE PLUS ROMIDEPSIN IN RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA PATIENTS
    Pellegrini, C.
    Broccoli, A.
    Casadei, B.
    Chiappella, A.
    Corradini, P.
    Derenzini, E.
    Dodero, A.
    Farina, L.
    Gandolfi, L.
    Ladetto, M.
    Monaco, F.
    Orsucci, L.
    Quirini, F.
    Salvi, F.
    Spina, F.
    Stefoni, V.
    Tonialini, L.
    Vitolo, U.
    Argnani, L.
    Cavo, M.
    Zinzani, P. L.
    HAEMATOLOGICA, 2015, 100 : 18 - 19
  • [49] Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Witzig, Thomas E.
    Sokol, Lubomir
    Kim, Won Seog
    de la Cruz Vicente, Fatima
    Caballero, Dolores
    Advani, Ranjana
    de Ona, Raquel
    Marin Niebla, Ana
    Jose Terol, Maria
    Domenech Eva, Domingo
    Bendris, Nawal
    Mackey Ahsan, Julie
    Leoni, Mollie
    Foss, Francine M.
    BLOOD, 2021, 138
  • [50] PRALATREXATE REVERSES THE TREND TO PROGRESSIVE RESISTANCE IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL)
    Coiffier, B.
    Zinzani, P.
    Koutsoukos, A.
    O'Connor, O.
    ANNALS OF ONCOLOGY, 2011, 22 : 202 - 202
12345